在住院精神卫生科进行甲状腺功能检测。
Thyroid function testing in an inpatient mental health unit.
作者信息
Garnier Kelly-Anne, Ismail Khairul A, Moylan Steven, Harvey Richard
机构信息
Mental Health, Drugs and Alcohol Services, Barwon Health, Geelong, VIC, Australia.
Mental Health, Drugs and Alcohol Services, Barwon Health, Geelong, VIC, and; Deakin University, Geelong, Australia
出版信息
Australas Psychiatry. 2016 Jun;24(3):256-60. doi: 10.1177/1039856215618522. Epub 2015 Dec 3.
OBJECTIVE
Thyroid function tests are a common screening investigation for patients admitted to a psychiatric inpatient unit.
METHOD
This study aimed to retrospectively assess the clinical utility of routine thyroid function testing performed on newly admitted psychiatric patients over a 4-year period in Victoria, Australia via chart review of all abnormal results identified.
RESULTS
Our retrospective audit revealed only two cases where identification of thyroid dysfunction informed patient management. In each case, the patient had a known history of thyroid disease. In this audit period, 893 patients required screening to yield one clinically relevant abnormal result, costing AU$24,975.57.
CONCLUSION
Such low clinical utility does not support routine admission thyroid function tests for psychiatric inpatients. We conclude that thyroid function tests should only be performed where the history and clinical signs suggest a likely contribution of thyroid dysfunction to the psychiatric presentation.
目的
甲状腺功能检查是精神科住院患者常见的筛查项目。
方法
本研究旨在通过对澳大利亚维多利亚州4年间新入院精神科患者所有异常结果的病历回顾，回顾性评估常规甲状腺功能检查的临床实用性。
结果
我们的回顾性审核仅发现两例甲状腺功能障碍的诊断对患者管理有指导意义的病例。在每个病例中，患者均有甲状腺疾病史。在本审核期间，893名患者需要进行筛查才能得出一项具有临床意义的异常结果，费用为24,975.57澳元。
结论
如此低的临床实用性不支持对精神科住院患者进行常规入院甲状腺功能检查。我们得出结论，只有在病史和临床体征提示甲状腺功能障碍可能是精神症状的病因时，才应进行甲状腺功能检查。
Zotero 插件